Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology treatment access and civil society activity in eleven countries

摘要

IntroductionThe 16 countries of the Eastern Europe and Central Asia (EECA) region are home to 6.6 million people in need of treatment for chronic hepatitis C virus (HCV) infection. Because of transformational change in HCV treatment, global efforts to address HCV are accelerating. Given its large regional burden, the EECA needs to ensure its inclusion in and benefit from any new developments.